Laboratory Evaluation of Acquired Coagulation Disorders
Richard A. Marlar PhD
Oklahoma City Veterans Administration Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Search for more papers by this authorKaterine Seywerd MD
Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Search for more papers by this authorRichard A. Marlar PhD
Oklahoma City Veterans Administration Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Search for more papers by this authorKaterine Seywerd MD
Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Search for more papers by this authorKandice Kottke-Marchant MD, PhD
Pathology & Laboratory Medicine Institute, Cleveland, OH, USA
Department of Pathology, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA
Hemostasis and Thrombosis, Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA
Search for more papers by this authorSummary
Acquired bleeding disorders manifest in most, if not all, disease processes. The mechanistic cause underlying acquired physiologic or pathophysiologic processes may be different but the final result is a high risk of bleeding or thrombosis. Acquired hemostatic problems are encountered in pediatrics, surgery, obstetrics, and primary care, as well as in the hospitalized patient. The coagulation laboratory plays an important role in the diagnosis of these secondary coagulopathies. This chapter will focus on three frequently acquired thrombotic and bleeding manifestations secondary to a primary pathophysiologic and physiologic process: disseminated intravascular coagulation, liver disease, and newborn physiology. The laboratory tests for diagnosis and assessment will be presented, along with a discussion of the mechanism(s) and clinical presentations for these acquired coagulation disorders.
References
- Zeerleder S, Hack CE, Wuillemin WA. Disseminated Intravascular Coagulation in Sepsis. Chest 2005; 128: 2864–2875.
-
Levi M, Ten Cate H. Current Concepts: Disseminated Intravascular Coagulation. N Engl J Med 1999; 34: 586–592.
10.1056/NEJM199908193410807 Google Scholar
- Gaines AR. Disseminated Intravascular Coagulation Associated with Acute Hemoglobinemia or Hemoglobinuria Following Rh o (D) Immune Globulin Intravenous Administration for Immune Thrombocytopenic Purpura. Blood 2005; 106: 1532–1537.
- Taylor FB Jr., Toh CH, Hoots WK et al. Towards a Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation. Thromb Haemost 2001; 86: 1327–1330.
- Slofstra SH, Spek CA, Ten Cate H. Review: Disseminated Intravascular Coagulation. Hematol J 2003; 4: 295–302.
- Kitchens CS. Disseminated Intravascular Coagulation. In: Kitchens CS, Alving BM, Kessler CM (eds.) Consultative Hemostasis and Thrombosis. Philadelphia, PA: W.B. Saunders Co.; 2002; 165–173.
- Toh CH, Dennis M. Disseminated Intravascular Coagulation: Old Disease, New Hope. BMJ 2003; 327: 974–977.
- Levi M. Current Understanding of Disseminated Intravascular Coagulation. Br J Haematol 2004; 124: 567–576.
- Schmaier AH, Thornburg CD, Pipe SW. Coagulation and Fibrinolysis. In: McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st edn. Philadelphia, PA: Saunders Elsevier Publishing; 2007; 731–742.
- Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 2007; 5 Suppl 1: 246–254.
- Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001; 102: 215–224.
- Loberg RD, Bradley DA, Tomlins SA et al. The Lethal Phenotype of Cancer. CA Cancer J Clin 2007; 57: 225–241.
- Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis. JAMA 2005; 293: 715–722.
- White RH, Chew HK, Zhou H et al. Incidence of Venous Thromboembolism in the Year Before the Diagnosis of Cancer in 528,693 Adults. Arch Int Med 2005; 165: 1782–1787.
- Stenina OI, Plow EF. MET Orchestrates Cancer and Blood Coagulation. Nat Med 2005; 11: 376–377.
- Fennerty A. Venous Thromboembolic Disease and Cancer. Postgrad Med J 2006; 82: 642–648.
- Khorana AA, Francis CW, Culakova E et al. Thromboembolism in Hospitalized Neutropenic Cancer Patients. J Clin Oncol 2006; 24: 484–490.
- Cavo M, Zamagni E, Cellini C et al. Deep-vein Thrombosis in Patients with Multiple Myeloma Receiving First-Line Thalidomide - Dexamethasone Therapy. Blood 2002; 100: 2272–2284.
- Kroger K, Weiland D, Ose C at al. Risk Factors for Venous Thromboembolic Events in Cancer Patients. Ann Oncol 2006; 17: 297–303.
- van Thiel DH, George M, Mindikoglu AL et al. Coagulation and Fibrinolysis in Individuals with Advanced Liver Disease. Turk J Gastroenterol 2004; 15: 67–72.
- Thachil J. Relevance of Clotting Tests in Liver Disease. Postgrad Med J 2008; 84: 177–181.
- Marlar RA. Determining the Model for End-Stage Liver Disease with Better Accuracy: Neutralizing the International Normalized Ratio Pitfalls. Hepatology 2007; 46: 290–296.
- Northup PG, Caldwell SH. New Concepts of Coagulation and Bleeding in Liver Disease. Intern Emerg Med 2010; 5: 3–6.
- DeSancho MT, Pastores SM. The Liver and Coagulation. In: Rodes J, Benhamou JP, Blei A et al. Textbook of Hepatology: From Basic Science to Clinical Practice, 3rd edn. Oxford: Blackwell Publishing; 2007; 255–263.
- Tripodi A, Chantarangkul V, Primignani M et al. The International Normalized Ration Calibrated for Cirrhosis (INR liver) Normalizes Prothrombin Time Results for Model for End Stage Liver Disease Calculation. Hepatology 2007; 46: 520–527.
- Chalmers EA. Neonatal Coagulation Problems. Arch Dis Child Fetal Neonatal Ed 2004; 89: F475–F478.
- Monagle P, Barnes C, Ignjatovic V et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362–372.
- Andrew M, Paes B, Milner R et al. Development of the Human Coagulation System in the Full-term Infant. Blood 1987; 70: 165–172.
- Davies MW, Woodgate PG. Coagulation Profiles in Neonates-If the Specimen Clots Repeat the Test. Crit Care Resusc 2002; 4: 18–20.
- Cerneca F, de Vonderweid U, Simeone R, Forleo V. The Importance of Hemocrit in the Interpretation of Coagulation Tests in the Full-Term Newborn Infant. Haematologica 1994; 79: 25–28.